CME Group (NASDAQ:CME) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Key Points

• JPMorgan Chase & Co. raised their target price for CME Group stock from $252.00 to $256.00, maintaining an "underweight" rating, which indicates a potential downside of 5.63% from the previous close.
• Several analysts have varying target prices and ratings for CME Group, with Piper Sandler setting an "overweight" rating and a target of $296.00, while Citigroup upgraded their rating to "buy" with a target of $300.00.
• CME Group's latest earnings report showed earnings per share of $2.96, beating expectations by $0.05, and a revenue increase of 10.4% from the same quarter last year.

CME Group (NASDAQ:CME - Get Free Report) had its target price lifted by equities research analysts at JPMorgan Chase & Co. from $252.00 to $256.00 in a report issued on Tuesday,MarketScreener reports. The brokerage presently has an "underweight" rating on the financial services provider's stock. JPMorgan Chase & Co.'s price objective suggests a potential downside of 5.63% from the company's previous close.

A number of other analysts also recently weighed in on the stock. Piper Sandler boosted their target price on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. UBS Group lowered their price objective on CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a research note on Monday, September 8th. TD Cowen lifted their target price on CME Group from $281.00 to $288.00 and gave the stock a "hold" rating in a report on Wednesday, October 8th. Barclays decreased their price target on CME Group from $298.00 to $280.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 8th. Finally, Citigroup raised shares of CME Group from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $275.00 to $300.00 in a research note on Thursday, September 25th. Seven equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $283.71.

CME Group Stock Performance

NASDAQ:CME opened at $271.28 on Tuesday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market cap of $97.76 billion, a price-to-earnings ratio of 26.26, a PEG ratio of 5.72 and a beta of 0.41. CME Group has a 1 year low of $213.94 and a 1 year high of $290.79. The stock's 50 day simple moving average is $268.57 and its two-hundred day simple moving average is $271.35.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. CME Group's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the firm posted $2.56 earnings per share. As a group, equities analysts anticipate that CME Group will post 10.49 earnings per share for the current fiscal year.

Insider Transactions at CME Group

In related news, General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction dated Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares in the company, valued at $2,056,962. The trade was a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of the business's stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the sale, the insider owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 13,043 shares of company stock worth $3,527,956. Corporate insiders own 0.30% of the company's stock.

Hedge Funds Weigh In On CME Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. GAMMA Investing LLC boosted its holdings in shares of CME Group by 24.5% in the 1st quarter. GAMMA Investing LLC now owns 7,007 shares of the financial services provider's stock valued at $1,859,000 after buying an additional 1,381 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its position in shares of CME Group by 63.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 105,044 shares of the financial services provider's stock worth $27,867,000 after purchasing an additional 40,592 shares in the last quarter. Dynamic Advisor Solutions LLC boosted its position in shares of CME Group by 3.1% in the 1st quarter. Dynamic Advisor Solutions LLC now owns 2,533 shares of the financial services provider's stock worth $672,000 after purchasing an additional 76 shares in the last quarter. Ritholtz Wealth Management boosted its holdings in CME Group by 10.3% in the first quarter. Ritholtz Wealth Management now owns 4,451 shares of the financial services provider's stock worth $1,181,000 after acquiring an additional 416 shares in the last quarter. Finally, Brighton Jones LLC acquired a new position in shares of CME Group during the first quarter valued at about $320,000. Hedge funds and other institutional investors own 87.75% of the company's stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.